A US study of 13,000 patients showed Tamoxifen reduced the rate of expected cancers from one in 130 to one in 236 – a cut of about 45%. The American researchers ended their trial early when they said the drug’s benefits became overwhelmingly obvious.
Other studies found that tamoxifen AND chemotherapy improved survival improved survival rates by about 4050% compared to taking one treatment or the other.
Should women taking tamoxifen avoid pregnancy?
Yes. Tamoxifen m…